Effects of microplusin, a copper-chelating antimicrobial peptide, against Cryptococcus neoformans

FEMS Microbiology Letters

Volumn 324, Issue 1, 2011, Pages 64-72

  Silva, Fernanda D ^a   Rossi, Diego C P ^a   Martinez, Luis R ^b,c   Frases, Susana ^d   Fonseca, Fernanda L ^e   Campos, Claudia Barbosa L ^f   Rodrigues, Marcio L ^e   Nosanchuk, Joshua D ^c   Daffre, Sirlei ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b LONG ISLAND UNIVERSITY   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d INSTITUTO NACIONAL DE METROLOGIA   (Brazil)

^e FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^f FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antimicrobial peptide; Cryptococcus neoformans; Microplusin

Indexed keywords

COPPER; LACCASE; MICROPLUSIN; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; ENZYME ACTIVITY; ENZYME INHIBITION; FUNGAL STRAIN; FUNGUS GROWTH; MICROBIAL RESPIRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CHELATING AGENTS; COPPER; CRYPTOCOCCUS NEOFORMANS; MICROBIAL SENSITIVITY TESTS; OXYGEN;

BOOPHILUS; BOOPHILUS MICROPLUS; FILOBASIDIELLA NEOFORMANS; FUNGI; MICROCOCCUS LUTEUS; RHIPICEPHALUS;

EID: 80053538956     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2011.02386.x     Document Type: Article

References (28)

1. Barbosa FM, Daffre S, Maldonado RA, Miranda A, Nimrichter L & Rodrigues ML (2007) Gomesin, a peptide produced by the spider Acanthoscurria gomesiana, is a potent anticryptococcal agent that acts in synergism with fluconazole. FEMS Microbiol Lett 274: 279-286.
2. Cox GM, Harrison TS, McDade HC, Taborda CP, Heinrich G, Casadevall A & Perfect JR (2003) Superoxide dismutase influences the virulence of Cryptococcus neoformans by affecting growth within macrophages. Infect Immun 71: 173-180.
3. Dan JM & Levitz SM (2006) Prospects for development of vaccines against fungal diseases. Drug Resist Updat 9: 105-110.
4. Davis-Kaplan SR, Askwith CC, Bengtzen AC, Radisky D & Kaplan J (1998) Chloride is an allosteric effector of copper assembly for the yeast multicopper oxidase Fet3p: an unexpected role for intracellular chloride channels. P Natl Acad Sci USA 95: 13641-13645.
5. Erickson T, Liu L, Gueyikian A, Zhu X, Gibbons J & Williamson PR (2001) Multiple virulence factors of Cryptococcus neoformans are dependent on VPH1. Mol Microbiol 42: 1121-1131.
6. Esteves E, Fogaca AC, Maldonado R et al. (2009) Antimicrobial activity in the tick Rhipicephalus (Boophilus) microplus eggs: cellular localization and temporal expression of microplusin during oogenesis and embryogenesis. Dev Comp Immunol 33: 913-919.
7. Fogaca AC, Lorenzini DM, Kaku LM, Esteves E, Bulet P & Daffre S (2004) Cysteine-rich antimicrobial peptides of the cattle tick Boophilus microplus: isolation, structural characterization and tissue expression profile. Dev Comp Immunol 28: 191-200.
8. Frases S, Salazar A, Dadachova E & Casadevall A (2007) Cryptococcus neoformans can utilize the bacterial melanin precursor homogentisic acid for fungal melanogenesis. Appl Environ Microbiol 73: 615-621.
9. Jiang N, Sun N, Xiao D, Pan J, Wang Y & Zhu X (2009) A copper-responsive factor gene CUF1 is required for copper induction of laccase in Cryptococcus neoformans. FEMS Microbiol Lett 296: 84-90.
10. Li L & Kaplan J (1998) Defects in the yeast high affinity iron transport system result in increased metal sensitivity because of the increased expression of transporters with a broad transition metal specificity. J Biol Chem 273: 22181-22187.
11. Martinez LR, Ntiamoah P, Gacser A, Casadevall A & Nosanchuk JD (2007) Voriconazole inhibits melanization in Cryptococcus neoformans. Antimicrob Agents Chemother 51: 4396-4400.
12. Mason HS (1955) Comparative biochemistry of the phenolase complex. Adv Enzymol Relat Subj Biochem 16: 105-184.
13. Nimrichter L, Frases S, Cinelli LP et al. (2007) Self-aggregation of Cryptococcus neoformans capsular glucuronoxylomannan is dependent on divalent cations. Eukaryot Cell 6: 1400-1410.
14. Nosanchuk JD & Casadevall A (2003) The contribution of melanin to microbial pathogenesis. Cell Microbiol 5: 203-223.
15. Nosanchuk JD & Casadevall A (2006) Impact of melanin on microbial virulence and clinical resistance to antimicrobial compounds. Antimicrob Agents Chemother 50: 3519-3528.
16. Nosanchuk JD, Ovalle R & Casadevall A (2001) Glyphosate inhibits melanization of Cryptococcus neoformans and prolongs survival of mice after systemic infection. J Infect Dis 183: 1093-1099.
17. O'Meara TR, Norton D, Price MS, Hay C, Clements MF, Nichols CB & Alspaugh JA (2010) Interaction of Cryptococcus neoformans Rim101 and protein kinase A regulates capsule. PLoS Pathog 6: e1000776.
18. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG & Chiller TM (2009) Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23: 525-530.
19. Perfect JR & Casadevall A (2002) Cryptococcosis. Infect Dis Clin North Am 16: 837-874, v-vi.
20. Perfect JR, Dismukes WE, Dromer F et al. (2010) Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America. Clin Infect Dis 50: 291-322.
21. Prado M, Silva MB, Laurenti R, Travassos LR & Taborda CP (2009) Mortality due to systemic mycoses as a primary cause of death or in association with AIDS in Brazil: a review from 1996 to 2006. Mem Inst Oswaldo Cruz 104: 513-521.
22. Silva FD, Rezende CA, Rossi DC et al. (2009) Structure and mode of action of microplusin, a copper II-chelating antimicrobial peptide from the cattle tick Rhipicephalus (Boophilus) microplus. J Biol Chem 284: 34735-34746.
23. Waterman SR, Hacham M, Hu G et al. (2007) Role of a CUF1/CTR4 copper regulatory axis in the virulence of Cryptococcus neoformans. J Clin Invest 117: 794-802.
24. Williamson PR, Wakamatsu K & Ito S (1998) Melanin biosynthesis in Cryptococcus neoformans. J Bacteriol 180: 1570-1572.
25. Zaragoza O & Casadevall A (2004) Experimental modulation of capsule size in Cryptococcus neoformans. Biol Proced Online 6: 10-15.
26. Zaragoza O, Rodrigues ML, De Jesus M, Frases S, Dadachova E & Casadevall A (2009) The capsule of the fungal pathogen Cryptococcus neoformans. Adv Appl Microbiol 68: 133-216.
27. Zhu X & Williamson PR (2004) Role of laccase in the biology and virulence of Cryptococcus neoformans. FEMS Yeast Res 5: 1-10.
28. Zhu X, Gibbons J, Zhang S & Williamson PR (2003) Copper-mediated reversal of defective laccase in a Deltavph1 avirulent mutant of Cryptococcus neoformans. Mol Microbiol 47: 1007-1014.